Prof. Robert Horvitz speaks with Bloomberg TV’s Caroline Hyde about new developments in creating more effective treatments for cancer. Horvitz explains that “biologists have figured out what it is that keeps the immune system from, in general, attacking cancer cells and have learned to unleash that innate ability and attack a cancer in a patient.”
Huffington Post contributor Derrick Crowe writes about a new MIT study that examines how increasing ocean acidification is impacting phytoplankton populations. The study showed how ocean acidification, “can throw off the balance of the plankton population, causing significant changes with profound implications for other species that depend on them.”
Prof. Kenneth Oye speaks with NPR’s Michaeleen Doucleff about the need for government regulation for bioengineered microbes that could be used to produce drugs like heroin. "Once a robust, easy-to-grow, heroin-producing yeast strain is out there, its control would be, in my view, virtually possible," Oye says.
MIT researchers have found that increasing ocean acidification will impact phytoplankton species worldwide, reports Michelle Toh for The Christian Science Monitor. Toh explains that the researchers found, “the balance of various plankton species will radically change as the world’s oceans increase in acidity over the next 85 years.”
MIT biologists have developed a genetically modified version of a common gut bacteria that could be used to treat disease, reports Catherine Woods for the PBS NewsHour. “You could engineer a Bacteroides to live in the gut and detect when inflammation is just starting…so that you can seek treatment right away,” explains Prof. Timothy Lu.
Researchers at MIT have developed tools that could one day allow intestinal bacteria to monitor, diagnose and treat diseases, writes Eryn Brown for The Los Angeles Times. "Just as you'd program computers, we're starting to learn how to program cells by modifying their DNA," says Prof. Timothy Lu.
Professor Kenneth Oye co-authored a commentary that urges regulators to work to prevent abuse following a study that finds that opioids can be home-manufactured by genetically engineering yeast, reports Eryn Brown for The Los Angeles Times. “[A]ll of these technical steps should be done beforehand,” says Oye. “Afterwards, it's too late."
Jessica Hamzelou writes for New Scientist that MIT researchers have been able to recover memories using light. The technique could eventually be used to help people with Alzheimer’s or amnesia. Hamzelou writes that Prof. Susumu Tonegawa, hopes to “develop a way to reactivate forgotten memories in people before the brain tissue itself is damaged, as is often the case in dementia.”
Washington Post reporter Rachel Feltman writes that MIT researchers have used optogenetics to reactive lost memories. The research indicates that, “retrograde amnesia -- where memories are lost after brain trauma -- may be more of a memory retrieval problem than an actual loss of data.”
According to AFP, MIT researchers were able to use a technology called optogenetics to retrieve lost memories. Professor Susumu Tonegawa explains that the research showed, “past memories may not be erased, but could simply be lost and inaccessible for recall."
Graduate student Dheeraj Roy speaks with Rachel Paiste of WBUR about a new study that indicates that memories lost to amnesia may be recalled by activating brain cells with light. Roy explains that the findings show that “in certain models of amnesia, memories do persist.”
After the release of a paper from U.C. Berkeley researchers detailing how certain strains of yeast may be used to produce opioids, Professor Kenneth Oye coauthored a commentary calling for regulation in the field, writes Lexi Pandell for Wired. “I haven’t seen anything quite like this before,” says Oye.
Rachel Feltman writes for The Washington Post about a commentary by Professor Kenneth Oye that calls for regulation of genetically modified yeast that could potentially produce opiates. “It’s not like tomorrow someone’s going to have a fully integrated, one-pot pathway to go from sugar to morphine,” says Oye. “But it’s coming.”
Michael Le Page writes for The New Scientist about Professor Kenneth Oye’s commentary on research indicating that genetically engineered yeasts could be used to produce opiates. Oye provides a number of policy recommendations to prevent illicit opium production, including outlawing the distribution of opiate-making yeast strains.
Professor Kenneth Oye has coauthored a commentary on a paper that demonstrates researchers may be close to being able to engineer morphine from yeast, writes Nicola Twilley for The New Yorker. The authors worry this “could put illicit opiate production into the hands of many more people, at a much smaller scale.”